Multiple myeloma:: Lusting for NF-κB

被引:61
作者
Gilmore, Thomas D. [1 ]
机构
[1] Boston Univ, Dept Biol, Boston, MA 02215 USA
关键词
D O I
10.1016/j.ccr.2007.07.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:95 / 97
页数:3
相关论文
共 11 条
[1]  
ANNUZIATA CM, 2007, CANC CELL
[2]   High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients [J].
Carrasco, DR ;
Tonon, G ;
Huang, YS ;
Zhang, YY ;
Sinha, R ;
Bin, F ;
Stewart, JP ;
Zhan, FG ;
Khatry, D ;
Protopopova, M ;
Protopopov, A ;
Sukhdeo, K ;
Hanamura, I ;
Stephens, O ;
Barlogie, B ;
Anderson, KC ;
Chin, L ;
Shaughnessy, JD ;
Brennan, C ;
DePinho, RA .
CANCER CELL, 2006, 9 (04) :313-325
[3]   Mutations in the NF-κB signaling pathway:: implications for human disease [J].
Courtois, G. ;
Gilmore, T. D. .
ONCOGENE, 2006, 25 (51) :6831-6843
[4]   MLN120B, a novel IκB kinase β inhibitor, blocks multiple myeloma cell growth in vitro and in vivo [J].
Hideshima, Teru ;
Neri, Paola ;
Tassone, Pierfranchesco ;
Yasui, Hiroshi ;
Ishitsuka, Kenji ;
Raje, Noopur ;
Chauhan, Dharminder ;
Podarl, Klaus ;
Mitsiades, Constantine ;
Dang, Lenny ;
Munshi, Nikhil ;
Richardson, Paul ;
Schenkein, David ;
Anderson, Kenneth C. .
CLINICAL CANCER RESEARCH, 2006, 12 (19) :5887-5894
[5]   Targeting NF-κB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth [J].
Jourdan, Michel ;
Moreaux, Jerome ;
De Vos, John ;
Hose, Dirk ;
Mahtouk, Karene ;
Abouladze, Matthieu ;
Robert, Nicolas ;
Baudard, Marion ;
Reme, Thierry ;
Romanelli, Angela ;
Goldschmidt, Hartmut ;
Rossi, Jean-Francois ;
Dreano, Michel ;
Klein, Bernard .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 138 (02) :160-168
[6]  
KEATS JJ, 2007, CANC CELL
[7]   Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib [J].
Mulligan, George ;
Mitsiades, Constantine ;
Bryant, Barb ;
Zhan, Fenghuang ;
Chng, Wee J. ;
Roels, Steven ;
Koenig, Erik ;
Fergus, Andrew ;
Huang, Yongsheng ;
Richardson, Paul ;
Trepicchio, William L. ;
Broyl, Annemiek ;
Sonneveld, Pieter ;
Shaughnessy, John D., Jr. ;
Bergsagel, P. Leif ;
Schenkein, David ;
Esseltine, Dixie-Lee ;
Boral, Anthony ;
Anderson, Kenneth C. .
BLOOD, 2007, 109 (08) :3177-3188
[8]   New drugs for myeloma [J].
Richardson, Paul G. ;
Mitsiades, Constantine ;
Schlossman, Robert ;
Munshi, Nikhil ;
Anderson, Kenneth .
ONCOLOGIST, 2007, 12 (06) :664-689
[9]   A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1 [J].
Shaughnessy, John D. ;
Zhan, Fenghuang ;
Burington, Bart E. ;
Huang, Yongsheng ;
Colla, Simona ;
Hanamura, Ichiro ;
Stewart, James P. ;
Kordsmeier, Bob ;
Randolph, Christopher ;
Williams, David R. ;
Xiao, Yan ;
Xu, Hongwei ;
Epstein, Joshua ;
Anaissie, Elias ;
Krishna, Somashekar G. ;
Cottler-Fox, Michele ;
Hollmig, Klaus ;
Mohiuddin, Abid ;
Pineda-Roman, Mauricio ;
Tricot, Guido ;
van Rhee, Frits ;
Sawyer, Jeffrey ;
Alsayed, Yazan ;
Walker, Ronald ;
Zangari, Maurizio ;
Crowley, John ;
Barlogie, Bart .
BLOOD, 2007, 109 (06) :2276-2284
[10]   Identification of a tumor-associated mutant form of the NF-κB RelA gene with reduced DNA-binding and transactivating activities [J].
Trecca D. ;
Guerrini L. ;
Fracchiolla N.S. ;
Pomati M. ;
Baldini L. ;
Maiolo A.T. ;
Neri A. .
Oncogene, 1997, 14 (7) :791-799